Arama Sonuçları - Anne‐Marie C. Dingemans
- Gösterilen 1 - 20 sonuçlar arası kayıtlar. 103
- Sonraki Sayfaya Git
-
1
Heat shock protein antagonists in early stage clinical trials for NSCLC Yazar: Lizza Hendriks, Anne‐Marie C. Dingemans
Baskı/Yayın Bilgisi 2017Revisão -
2
Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm Yazar: Thierry Berghmans, Anne‐Marie C. Dingemans, Lizza Hendriks, J. Cadranel
Baskı/Yayın Bilgisi 2020Artigo -
3
Immunotherapy: From Advanced NSCLC to Early Stages, an Evolving Concept Yazar: Thierry Berghmans, Valérie Durieux, Lizza Hendriks, Anne‐Marie C. Dingemans
Baskı/Yayın Bilgisi 2020Revisão -
4
Response Assessment Using <sup>18</sup>F-FDG PET Early in the Course of Radiotherapy Correlates with Survival in Advanced-Stage Non–Small Cell Lung Cancer Yazar: Wouter van Elmpt, Michel Öllers, Anne‐Marie C. Dingemans, Philippe Lambin, Dirk De Ruysscher
Baskı/Yayın Bilgisi 2012Artigo -
5
MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer Yazar: Jih‐Hsiang Lee, Johannes Voortman, Anne‐Marie C. Dingemans, Donna Voeller, Trung C. Pham, Yisong Wang, Giuseppe Giaccone
Baskı/Yayın Bilgisi 2011Artigo -
6
Management of stage I and II nonsmall cell lung cancer Yazar: Fiona McDonald, Michèle De Waele, Lizza Hendriks, Corinne Faivre‐Finn, Anne‐Marie C. Dingemans, Paul Van Schil
Baskı/Yayın Bilgisi 2016Revisão -
7
New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management Yazar: Jules L. Derks, Noémie Leblay, Sylvie Lantuéjoul, Anne‐Marie C. Dingemans, Ernst‐Jan M. Speel, Lynnette Fernández-Cuesta
Baskı/Yayın Bilgisi 2018Revisão -
8
Effect of Bisphosphonates, Denosumab, and Radioisotopes on Bone Pain and Quality of Life in Patients with Non–Small Cell Lung Cancer and Bone Metastases: A Systematic Review Yazar: Lizza Hendriks, B.C.M. Hermans, M.H.J. van den Beuken-van Everdingen, Monique Hochstenbag, Anne‐Marie C. Dingemans
Baskı/Yayın Bilgisi 2015Revisão -
9
[18F]fluorodeoxyglucose Uptake Patterns in Lung Before Radiotherapy Identify Areas More Susceptible to Radiation-Induced Lung Toxicity in Non-Small-Cell Lung Cancer Patients Yazar: Steven Petit, Wouter J. C. van Elmpt, Cary Oberije, Erik Vegt, Anne‐Marie C. Dingemans, Philippe Lambin, André Dekker, Dirk De Ruysscher
Baskı/Yayın Bilgisi 2010Artigo -
10
Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer Yazar: Anne‐Marie C. Dingemans, Vivian van den Boogaart, Bettine A.H. Vosse, Robert‐Jan van Suylen, Arjan W. Griffioen, Victor L. Thijssen
Baskı/Yayın Bilgisi 2010Artigo -
11
-
12
Defining Synchronous Oligometastatic Non–Small Cell Lung Cancer: A Systematic Review Yazar: Niccolò Giaj-Levra, Matteo Giaj Levra, Valérie Durieux, Silvia Novello, Benjamin Besse, Baktiar Hasan, Lizza Hendriks, Antonin Lévy, Anne‐Marie C. Dingemans, Thierry Berghmans
Baskı/Yayın Bilgisi 2019Revisão -
13
Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study Yazar: Lizza Hendriks, Jules L. Derks, Pieter E. Postmus, Ronald Damhuis, Ruud Houben, Esther G.C. Troost, M. Hochstenbag, Egbert F. Smit, Anne‐Marie C. Dingemans
Baskı/Yayın Bilgisi 2015Artigo -
14
Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment? Yazar: Joline S.W. Lind, Martijn R. Meijerink, Anne‐Marie C. Dingemans, Cornelis van Kuijk, Michel Öllers, Dirk De Ruysscher, Pieter E. Postmus, Egbert F. Smit
Baskı/Yayın Bilgisi 2010Artigo -
15
Progression-Free Survival and Overall Survival Beyond 5 Years of NSCLC Patients With Synchronous Oligometastases Treated in a Prospective Phase II Trial (NCT 01282450) Yazar: Dirk De Ruysscher, Rinus Wanders, Lizza Hendriks, Angela van Baardwijk, Bart Reymen, Ruud Houben, Gerben Bootsma, Cordula Pitz, Linda van Eijsden, Anne‐Marie C. Dingemans
Baskı/Yayın Bilgisi 2018Artigo -
16
Nuclear transcription factor κ B activation and protein turnover adaptations in skeletal muscle of patients with progressive stages of lung cancer cachexia Yazar: Celine M. Op den Kamp, Ramon Langen, Frank J. M. Snepvangers, Chiel C. de Theije, Johanna M Schellekens, Fabian Laugs, Anne‐Marie C. Dingemans, Annemie Schols
Baskı/Yayın Bilgisi 2013Artigo -
17
Mature Results of an Individualized Radiation Dose Prescription Study Based on Normal Tissue Constraints in Stages I to III Non–Small-Cell Lung Cancer Yazar: Angela van Baardwijk, S. Wanders, Liesbeth Boersma, Jacques Borger, Michel Öllers, Anne‐Marie C. Dingemans, Gerben Bootsma, Wiel Geraedts, Cordula Pitz, Ragnar Lunde, Philippe Lambin, Dirk De Ruysscher
Baskı/Yayın Bilgisi 2010Artigo -
18
Is the sum of positive neuroendocrine immunohistochemical stains useful for diagnosis of large cell neuroendocrine carcinoma (LCNEC) on biopsy specimens? Yazar: Jules L. Derks, Anne‐Marie C. Dingemans, Robert‐Jan van Suylen, Michael A. den Bakker, Ronald Damhuis, Esther C. van den Broek, Ernst‐Jan Speel, Erik Thunnissen
Baskı/Yayın Bilgisi 2018Artigo -
19
Handgrip weakness, low fat‐free mass, and overall survival in non‐small cell lung cancer treated with curative‐intent radiotherapy Yazar: Chris Burtin, Jacques Bezuidenhout, Karin J.C. Sanders, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols, Stéphanie Peeters, Martijn A. Spruit, Dirk K.M. De Ruysscher
Baskı/Yayın Bilgisi 2020Artigo -
20
Pre-cachexia in patients with stages I–III non-small cell lung cancer: Systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome sy... Yazar: Celine M. Op den Kamp, Ramon Langen, Ronnie Minnaard, Marco Kelders, Frank J. M. Snepvangers, M. K.C. Hesselink, Anne‐Marie C. Dingemans, Annemie M.W.J. Schols
Baskı/Yayın Bilgisi 2011Artigo
Arama Araçları:
İlgili Konular
Medicine
Internal medicine
Lung cancer
Oncology
Cancer
Biology
Chemotherapy
Radiation therapy
Paleontology
Pathology
Stage (stratigraphy)
Radiology
Confidence interval
Surgery
Clinical trial
Cancer research
Adenocarcinoma
Cohort
Disease
Gastroenterology
Gene
Immunotherapy
Malignant pleural effusion
Nuclear medicine
Clinical endpoint
Crizotinib
Epidermal growth factor receptor
Hazard ratio
Immunology
Intensive care medicine